Related Experiment Video

Updated: Jul 8, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

Predictors of attrition among high risk HIV-infected participants enrolled in a multi-site prevention trial

Mallory O Johnson1, Samantha E Dilworth, Torsten B Neilands

  • 1University of California, 50 Beale Street, San Francisco, CA 94105, USA. Mallory.Johnson@ucsf.edu

AIDS and Behavior
|January 19, 2008
PubMed

Insights

Younger age, depression, and not using antiretroviral therapy (ART) predict dropout in HIV prevention trials. Targeted retention strategies are needed for these high-risk groups to ensure trial integrity.

Area of Science:

  • Clinical Trials
  • HIV Prevention Research
  • Public Health

Background:

  • Participant retention is crucial for the success of HIV prevention trials.
  • Understanding factors associated with dropout is essential for improving trial design and participant engagement.

Purpose of the Study:

  • To identify predictors of trial dropout among HIV-infected participants in a multi-site HIV prevention trial.
  • To assess potential biases in trial outcomes due to differential dropout patterns.

Main Methods:

  • Analysis of demographic, clinical, and behavioral data from participants in a multi-site HIV prevention trial.
  • Comparison of characteristics between participants who dropped out and those who continued in the trial.

Main Results:

  • Dropouts were significantly more likely to be younger, depressed, and not on antiretroviral therapy (ART).
  • No significant differences were observed in other background characteristics, substance use, or transmission risks between dropouts and completers.
  • These findings suggest no direct evidence of dropout bias impacting key trial outcomes.

Conclusions:

  • Early detection and treatment of depression may improve retention in HIV prevention trials.
  • Targeted interventions to retain younger participants and those not on ART are warranted.
  • Ensuring participant retention is vital for the validity and generalizability of HIV prevention trial findings.

Related Concept Videos

Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...